Journals / European Journal of Therapeutics / 2020 / Cilt: 26 - Sayı: 2

Baseline Hemoglobin Levels Predict AllCause Mortality After Saphenous Vein Graft Interventions

Pages
103–107
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A hemoglobin cut-off 12.55 g/dL discriminated all-cause mortality with an accuracy of 85% (sensitivity: 83,3%, specificity: 76.4%, p=

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Reduced baseline hemoglobin level is associated with worse outcomes in many cardiovascular conditions including percutaneous interventions of native coronary arteries.
📊
Key Findings & Data:Metods: In this study, we evaluated baseline hemoglobin levels of 105 patients undergoing saphenous vein graft intervention.
💡
Conclusion & Impact:A hemoglobin cut-off 12.55 g/dL discriminated all-cause mortality with an accuracy of 85% (sensitivity: 83,3%, specificity: 76.4%, p=
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Reduced baseline hemoglobin level is associated with worse outcomes in many cardiovascular conditions including percutaneous interventions of native coronary arteries. However, this relationship has not been studied in saphenous vein graft disease undergoing elective percutaneous intervention. Metods: In this study, we evaluated baseline hemoglobin levels of 105 patients undergoing saphenous vein graft intervention. The mean follow-up was 42.4±18.4 months, and the end-point of our study was all-cause mortality. Results: Twelve patients suffered all-cause mortality, and these patients’ mean baseline hemoglobin levels were 2 g/dl lower (11.7±1.0 vs. 13.7±1.5, p=0.005), and their ejection fractions were 22% lower (49.3±10,8 vs. 38.3±12,4, p=0.014) than those of the patients without all-cause mortality. A hemoglobin cut-off 12.55 g/dL discriminated all-cause mortality with an accuracy of 85% (sensitivity: 83,3%, specificity: 76.4%, p=

🔖

Cite This Article

DİKER, E., ÇELEBİ, S., TEK, M., BERKALP, B., ÖZGEYİK, M., AMASYALI, B., ÇETİN, M. S. (2022). Baseline Hemoglobin Levels Predict AllCause Mortality After Saphenous Vein Graft Interventions. European Journal of Therapeutics, Cilt: 26 - Sayı: 2, 103–107. https://ajindex.com/articles/512179

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Brilakis ES, O’Donnell CI, Penny W, et al. Percutaneous coronary intervention in native coronary arteries versus bypass grafts in patients with prior coronary artery bypass graft surgery: insights from the veterans affairs clinical assessment, reporting, and tracking program. JACC Cardiovasc Interv. 2016;9:884–893.
  2. Guedeney P, Sorrentino S, Claessen B, Mehran R. The link between anemia and adverse outcomes in patients with acute coronary syndrome. Expert Review of Cardiovascular Therapy. Volume 17, Issue 3, 4 March 2019, Pages 151-159
  3. Sulaiman K, Prashanth P, Al-Zakwani I, et al. Impact of anemia on in-hospital, one-month and one-year mortality in patients with acute coronary syndrome from the Middle East. Clin Med Res. 2012;10:65–71.
  4. Wang X, Qiu M, Qi J, et al. Impact of anemia on long-term ischemic events and bleeding events in patients undergoing percutaneous coronary intervention: a system review and meta-analysis. J Thorac Dis. 2015;7:2041–2052.
  5. Yazji K, Abdul F, Elangovan S, et al. Baseline anemia in patients undergoing percutaneous coronary intervention after an acute coronary syndrome-A paradox of high bleeding risk, high ischemic risk, and complex coronary disease. J Interv Cardiol. 2017;30:491–499.
  6. Poludasu S, Marmur JD, Weedon J, et al. Effect of hemoglobin level on long-term all-cause mortality after percutaneous coronary intervention in African-Americans. Am J Cardiol. 2009 Apr 15;103(8):1078-82.
  7. Lopes RD, Mehta RH, Hafley GE, for the PREVENT IV Investigators, et al. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation. 2012;125:749–75.
  8. Heuser R, Moualla SK. Choose your battles wisely! Saphenous vein graft chronic total occlusion interventions, a path less traveled, a frontier to be mostly avoided. Catheter Cardiovasc Interv. 2014 Jun 1;83(7):1033-4.
  9. Varghese, I, Samuel, J, Banerjee, S, Brilakis, ES. Comparison of percutaneous coronary interventions in native coronary arteries vs. bypass grafts in patient with prior coronary artery bypass graft surgery. Cardiovasc Revasc Med 2009; 10: 103– 109. 10. Mehta RH, Honeycutt E, Shaw LK, et al. Clinical correlates of longterm mortality after percutaneous interventions of saphenous vein grafts. Am Heart J. 2006 Oct;152(4):801-6. 11. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005 Apr 26;111(16):2042-9. 12. Arant CB, Wessel TR, Olson MB